PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-73.23%
Negative net income growth while MCHP stands at 27.74%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.44%
Negative yoy D&A while MCHP is 11.58%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
8050.00%
Some yoy growth while MCHP is negative at -117.10%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-16.67%
Both cut yoy SBC, with MCHP at -0.24%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
601.24%
Slight usage while MCHP is negative at -23.59%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
382.08%
AR growth well above MCHP's 81.90%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-225.64%
Both reduce yoy inventory, with MCHP at -35.71%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
48.94%
Lower AP growth vs. MCHP's 2637.30%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
346.96%
Some yoy usage while MCHP is negative at -46.83%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
2900.00%
Well above MCHP's 175.86%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
12.02%
Operating cash flow growth 1.25-1.5x MCHP's 10.92%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-24.19%
Both yoy lines negative, with MCHP at -46.39%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
24.19%
Acquisition growth of 24.19% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-19.05%
Both yoy lines negative, with MCHP at -1224.42%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-14.13%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-25.26%
Both yoy lines negative, with MCHP at -2593.97%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-84.02%
Both yoy lines negative, with MCHP at -1326.37%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
113.16%
Lower share issuance yoy vs. MCHP's 287.01%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-8.62%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.